Iambic to Participate in March Investor Conferences

Audio By Carbonatix

SAN DIEGO--(BUSINESS WIRE)--Mar 2, 2026--

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven drug discovery platform, today announced its participation in upcoming March investor conferences:

• Leerink Global Healthcare Conference: March 9-12
• Jeffries Biotech Summit: March 10-11
• KeyBanc Healthcare Forum: March 18-19

About Iambic

Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, internally and with partners, to address urgent unmet patient need as well as providing access to its industry-leading technology. Learn more about the Iambic team, platform, pipeline, and partnerships at Iambic.ai

View source version on businesswire.com:https://www.businesswire.com/news/home/20260302662667/en/

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: TECHNOLOGY CLINICAL TRIALS HEALTH TECHNOLOGY SOFTWARE BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH ARTIFICIAL INTELLIGENCE

SOURCE: Iambic

Copyright Business Wire 2026.

PUB: 03/02/2026 08:00 AM/DISC: 03/02/2026 08:00 AM

http://www.businesswire.com/news/home/20260302662667/en